嘉实医药健康100ETF(515960)利润分配表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 收入 |
-36,551,210.01 |
-48,062,541.56 |
-27,750,712.66 |
-23,004,762.81 |
| 利息合计 |
16,088.31 |
8,147.75 |
16,726.31 |
8,006.29 |
| 其中：存款利息收入 |
16,088.31 |
8,147.75 |
16,726.31 |
8,006.29 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-41,074,042.53 |
-30,456,568.56 |
-30,694,482.49 |
-5,522,453.64 |
| 其中：股票投资收益 |
-46,231,971.77 |
-34,048,533.83 |
-35,044,531.81 |
-8,843,218.27 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
47,164.09 |
47,164.09 |
22,400.05 |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
5,110,765.15 |
3,544,801.18 |
4,327,649.27 |
3,320,764.63 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
4,354,358.99 |
-17,684,836.53 |
2,750,336.87 |
-17,505,345.39 |
| 其他收入 |
152,385.22 |
70,715.78 |
176,706.65 |
15,029.93 |
| 费用 |
1,774,281.20 |
922,653.80 |
2,080,290.97 |
1,043,677.01 |
| 管理人报酬 |
1,231,290.86 |
638,596.47 |
1,469,680.79 |
734,160.92 |
| 基金托管费 |
246,258.18 |
127,719.25 |
293,936.10 |
146,832.20 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
296,731.94 |
156,337.86 |
316,674.04 |
162,683.89 |
| 利润总额 |
-38,325,491.21 |
-48,985,195.36 |
-29,831,003.63 |
-24,048,439.82 |
微信公众号
证券之星APP
基本资料
